Enhanced B-Raf-mediated NRF2 gene transcription and HATs-mediated NRF2 protein acetylation contributes to ABCC1-mediated chemoresistance and glutathione-mediated survival in acquired topoisomerase II poison-resistant cancer cells

Huang Hui Chen, Hsin Huei Chang, Jang Yang Chang, Ya Chu Tang, Yung Chi Cheng, Li Mei Lin, Shu Ying Cheng, Chih Hsiang Huang, Man Wu Sun, Chiung Tong Chen, Ching Chuan Kuo

研究成果: Article

4 引文 (Scopus)

摘要

Nuclear factor erythroid-2-related factor 2 (NRF2) mainly regulates transcriptional activation through antioxidant-responsive elements (AREs) present in the promoters of NRF2 target genes. Recently, we found that NRF2 was overexpressed in a KB-derived drug-resistant cancer cell panel. In this panel, KB-7D cells, which show acquired resistance to topoisomerase II (Top II) poisons, exhibited the highest NRF2 activation. To investigate whether NRF2 directly contributed to acquired resistance against Top II poisons, we manipulated NRF2 by genetic and pharmacological approaches. The result demonstrated that silencing of NRF2 by RNA interference increased the sensitivity and treatment with NRF2 activator decreased the sensitivity of KB and KB-7D cells toward Top II poisons. Further, increased B-Raf–mediated NRF2 gene transcription and HATs–mediated NRF2 protein acetylation activated NRF2 signaling in KB-7D cells. Moreover, increased binding of NRF2 to an ARE in the promoter of ATP-binding cassette subfamily C member 1 (ABCC1) directly contributed to Top II poison resistance. In addition, activation of NRF2 increased glutathione level and antioxidant capacity in KB-7D cells compared with that in KB cells; moreover, high glutathione level provided survival advantage to KB-7D cells. Our study is the first to show that aberrant NRF2 activation is via increased B-Raf–mediated NRF2 gene transcription and HATs–mediated NRF2 protein acetylation, which increases the acquired resistance and promote the survival of Top II poison-resistant cancer cells. Importantly, NRF2 downstream effectors ABCC1 and glutathione directly contribute to acquired resistance and survival, respectively. These results suggest that blockade of NRF2 signaling may enhance therapeutic efficacy and reduce the survival of Top II poison-refractory tumors in clinical.

原文English
頁(從 - 到)505-518
頁數14
期刊Free Radical Biology and Medicine
113
DOIs
出版狀態Published - 2017 十二月

指紋

KB Cells
Acetylation
Type II DNA Topoisomerase
Poisons
Transcription
Glutathione
Genes
Cells
Chemical activation
Neoplasms
Proteins
Antioxidants
RNA Interference
Refractory materials
Transcriptional Activation
multidrug resistance-associated protein 1
Tumors
Pharmacology
RNA
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Physiology (medical)

引用此文

Chen, Huang Hui ; Chang, Hsin Huei ; Chang, Jang Yang ; Tang, Ya Chu ; Cheng, Yung Chi ; Lin, Li Mei ; Cheng, Shu Ying ; Huang, Chih Hsiang ; Sun, Man Wu ; Chen, Chiung Tong ; Kuo, Ching Chuan. / Enhanced B-Raf-mediated NRF2 gene transcription and HATs-mediated NRF2 protein acetylation contributes to ABCC1-mediated chemoresistance and glutathione-mediated survival in acquired topoisomerase II poison-resistant cancer cells. 於: Free Radical Biology and Medicine. 2017 ; 卷 113. 頁 505-518.
@article{00c9dec234474c2d96de3dd0ef75345a,
title = "Enhanced B-Raf-mediated NRF2 gene transcription and HATs-mediated NRF2 protein acetylation contributes to ABCC1-mediated chemoresistance and glutathione-mediated survival in acquired topoisomerase II poison-resistant cancer cells",
abstract = "Nuclear factor erythroid-2-related factor 2 (NRF2) mainly regulates transcriptional activation through antioxidant-responsive elements (AREs) present in the promoters of NRF2 target genes. Recently, we found that NRF2 was overexpressed in a KB-derived drug-resistant cancer cell panel. In this panel, KB-7D cells, which show acquired resistance to topoisomerase II (Top II) poisons, exhibited the highest NRF2 activation. To investigate whether NRF2 directly contributed to acquired resistance against Top II poisons, we manipulated NRF2 by genetic and pharmacological approaches. The result demonstrated that silencing of NRF2 by RNA interference increased the sensitivity and treatment with NRF2 activator decreased the sensitivity of KB and KB-7D cells toward Top II poisons. Further, increased B-Raf–mediated NRF2 gene transcription and HATs–mediated NRF2 protein acetylation activated NRF2 signaling in KB-7D cells. Moreover, increased binding of NRF2 to an ARE in the promoter of ATP-binding cassette subfamily C member 1 (ABCC1) directly contributed to Top II poison resistance. In addition, activation of NRF2 increased glutathione level and antioxidant capacity in KB-7D cells compared with that in KB cells; moreover, high glutathione level provided survival advantage to KB-7D cells. Our study is the first to show that aberrant NRF2 activation is via increased B-Raf–mediated NRF2 gene transcription and HATs–mediated NRF2 protein acetylation, which increases the acquired resistance and promote the survival of Top II poison-resistant cancer cells. Importantly, NRF2 downstream effectors ABCC1 and glutathione directly contribute to acquired resistance and survival, respectively. These results suggest that blockade of NRF2 signaling may enhance therapeutic efficacy and reduce the survival of Top II poison-refractory tumors in clinical.",
author = "Chen, {Huang Hui} and Chang, {Hsin Huei} and Chang, {Jang Yang} and Tang, {Ya Chu} and Cheng, {Yung Chi} and Lin, {Li Mei} and Cheng, {Shu Ying} and Huang, {Chih Hsiang} and Sun, {Man Wu} and Chen, {Chiung Tong} and Kuo, {Ching Chuan}",
year = "2017",
month = "12",
doi = "10.1016/j.freeradbiomed.2017.10.375",
language = "English",
volume = "113",
pages = "505--518",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier Inc.",

}

Enhanced B-Raf-mediated NRF2 gene transcription and HATs-mediated NRF2 protein acetylation contributes to ABCC1-mediated chemoresistance and glutathione-mediated survival in acquired topoisomerase II poison-resistant cancer cells. / Chen, Huang Hui; Chang, Hsin Huei; Chang, Jang Yang; Tang, Ya Chu; Cheng, Yung Chi; Lin, Li Mei; Cheng, Shu Ying; Huang, Chih Hsiang; Sun, Man Wu; Chen, Chiung Tong; Kuo, Ching Chuan.

於: Free Radical Biology and Medicine, 卷 113, 12.2017, p. 505-518.

研究成果: Article

TY - JOUR

T1 - Enhanced B-Raf-mediated NRF2 gene transcription and HATs-mediated NRF2 protein acetylation contributes to ABCC1-mediated chemoresistance and glutathione-mediated survival in acquired topoisomerase II poison-resistant cancer cells

AU - Chen, Huang Hui

AU - Chang, Hsin Huei

AU - Chang, Jang Yang

AU - Tang, Ya Chu

AU - Cheng, Yung Chi

AU - Lin, Li Mei

AU - Cheng, Shu Ying

AU - Huang, Chih Hsiang

AU - Sun, Man Wu

AU - Chen, Chiung Tong

AU - Kuo, Ching Chuan

PY - 2017/12

Y1 - 2017/12

N2 - Nuclear factor erythroid-2-related factor 2 (NRF2) mainly regulates transcriptional activation through antioxidant-responsive elements (AREs) present in the promoters of NRF2 target genes. Recently, we found that NRF2 was overexpressed in a KB-derived drug-resistant cancer cell panel. In this panel, KB-7D cells, which show acquired resistance to topoisomerase II (Top II) poisons, exhibited the highest NRF2 activation. To investigate whether NRF2 directly contributed to acquired resistance against Top II poisons, we manipulated NRF2 by genetic and pharmacological approaches. The result demonstrated that silencing of NRF2 by RNA interference increased the sensitivity and treatment with NRF2 activator decreased the sensitivity of KB and KB-7D cells toward Top II poisons. Further, increased B-Raf–mediated NRF2 gene transcription and HATs–mediated NRF2 protein acetylation activated NRF2 signaling in KB-7D cells. Moreover, increased binding of NRF2 to an ARE in the promoter of ATP-binding cassette subfamily C member 1 (ABCC1) directly contributed to Top II poison resistance. In addition, activation of NRF2 increased glutathione level and antioxidant capacity in KB-7D cells compared with that in KB cells; moreover, high glutathione level provided survival advantage to KB-7D cells. Our study is the first to show that aberrant NRF2 activation is via increased B-Raf–mediated NRF2 gene transcription and HATs–mediated NRF2 protein acetylation, which increases the acquired resistance and promote the survival of Top II poison-resistant cancer cells. Importantly, NRF2 downstream effectors ABCC1 and glutathione directly contribute to acquired resistance and survival, respectively. These results suggest that blockade of NRF2 signaling may enhance therapeutic efficacy and reduce the survival of Top II poison-refractory tumors in clinical.

AB - Nuclear factor erythroid-2-related factor 2 (NRF2) mainly regulates transcriptional activation through antioxidant-responsive elements (AREs) present in the promoters of NRF2 target genes. Recently, we found that NRF2 was overexpressed in a KB-derived drug-resistant cancer cell panel. In this panel, KB-7D cells, which show acquired resistance to topoisomerase II (Top II) poisons, exhibited the highest NRF2 activation. To investigate whether NRF2 directly contributed to acquired resistance against Top II poisons, we manipulated NRF2 by genetic and pharmacological approaches. The result demonstrated that silencing of NRF2 by RNA interference increased the sensitivity and treatment with NRF2 activator decreased the sensitivity of KB and KB-7D cells toward Top II poisons. Further, increased B-Raf–mediated NRF2 gene transcription and HATs–mediated NRF2 protein acetylation activated NRF2 signaling in KB-7D cells. Moreover, increased binding of NRF2 to an ARE in the promoter of ATP-binding cassette subfamily C member 1 (ABCC1) directly contributed to Top II poison resistance. In addition, activation of NRF2 increased glutathione level and antioxidant capacity in KB-7D cells compared with that in KB cells; moreover, high glutathione level provided survival advantage to KB-7D cells. Our study is the first to show that aberrant NRF2 activation is via increased B-Raf–mediated NRF2 gene transcription and HATs–mediated NRF2 protein acetylation, which increases the acquired resistance and promote the survival of Top II poison-resistant cancer cells. Importantly, NRF2 downstream effectors ABCC1 and glutathione directly contribute to acquired resistance and survival, respectively. These results suggest that blockade of NRF2 signaling may enhance therapeutic efficacy and reduce the survival of Top II poison-refractory tumors in clinical.

UR - http://www.scopus.com/inward/record.url?scp=85032692153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032692153&partnerID=8YFLogxK

U2 - 10.1016/j.freeradbiomed.2017.10.375

DO - 10.1016/j.freeradbiomed.2017.10.375

M3 - Article

C2 - 29080842

AN - SCOPUS:85032692153

VL - 113

SP - 505

EP - 518

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

ER -